Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma’s reputation continues to slide

July 1, 2004

The reputation of the pharmaceutical industry in the US continues to decline as the public grows increasingly concerned about the …

News

Fast4wD expands clinical trial focus

July 1, 2004

Ogilvy Public Relations Worldwide and Shire Health Group have merged part of their operations to form Fast4wD Ogilvy, a clinical …

News

US parallel trade to be legalised after Republican U-turn

June 29, 2004

Re-importation of cheaper medicines from Canada and other countries into the US looks certain to be legalised after the Bush …

News

Sanofi executives take control of new boardroom

June 24, 2004

The soon to be created Sanofi-Aventis will be dominated by executives from Sanofi-Synthelabo who have pledged to deliver "swift integration" …

News

GlaxoSmithKline to publish trial data online

June 24, 2004

GlaxoSmithKline has announced it is to make data from all of its trials available online in an effort to counter …

News

Contract research looks East

June 24, 2004

Contract research organisations (CRO) have benefited from the pressure on the pharmaceutical industry to maintain a flow of blockbusters at …

Feature

Study finds dementia risk for HRT

June 24, 2004

A new study has found that both oestrogen-only and oestrogen plus progestogen hormone replacement therapies may increase the risk of …

News

Positive opinion on Raptiva in Europe

June 24, 2004

Raptiva, a new psoriasis treatment to be marketed by Serono in Europe has gained a positive opinion from the EMEA.The …

News

New drugs dominate NICE’s latest programme

June 24, 2004

News

Exanta launched in first market

June 23, 2004

AstraZeneca's new oral anticoagulant Exanta has been launched in Germany, its first global market.The drug is the first in a …

News

Are you structured for success?

June 18, 2004

In a world of constant change, why have many pharma companies stuck to traditional organisational structures? Are they really the …

Feature

Regulators tighten up Crestor’s European prescribing

June 17, 2004

News

Schering restructures for long-term growth

June 17, 2004

German pharmaceutical company Schering AG will no longer conduct research and development into cardiovascular or, with a few exceptions, central …

News

Cancer tsar sets out plan to end postcode prescribing

June 15, 2004

The government has promised to eliminate persistent variations in access to cancer drugs across England and Wales, and has unveiled …

News

Pharmacists to take on public health role

June 15, 2004

The government's drive to transform pharmacists into leading frontline healthcare professionals is to be spearheaded by a new consortium of …

News

Xenova’s cocaine vaccine shows promise

June 15, 2004

Cocaine addicts could be helped by a vaccine currently in development by UK biotech company Xenova, phase II results from …

News

Mental health research network launched

June 10, 2004

News

Abbott buys heart drug from Aventis for $300 million

June 10, 2004

Chicago-based Abbott Laboratories has bought the marketing and manufacturing rights for cardiovascular drug trandolapril from Aventis, in a deal worth …

News

New schizophrenia drug Abilify gets European go-ahead

June 10, 2004

Abilify, Bristol-Myers Squibb and Otsuka's antipsychotic has received European Union marketing approval and will be promoted for having fewer side …

News

Novo Nordisk claims new product superior to Lantus

June 10, 2004

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026